{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:42Z","timestamp":1790063262538,"version":"4.0.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhlto.2025.100331","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:04:36Z","timestamp":1751007876000},"page":"100331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pediatric heart failure: Current approach and treatment"],"prefix":"10.1016","volume":"9","author":[{"given":"Benjamin A.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-981X","authenticated-orcid":false,"given":"Shelley D.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2025.100331_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCHEARTFAILURE.108.820217","article-title":"Heart failure in children: part I: history, etiology, and pathophysiology","volume":"2","author":"Hsu","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib2","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCHEARTFAILURE.108.772756","article-title":"The \"modern\" view of heart failure: How did we get here?","volume":"1","author":"Katz","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00246-017-1787-2","article-title":"Systematic literature review on the incidence and prevalence of heart failure in children and adolescents","volume":"39","author":"Shaddy","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib5","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2022.03.336","article-title":"Burden of pediatric heart failure in the United States","volume":"79","author":"Amdani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardfail.2014.10.011","article-title":"Pediatric versus adult cardiomyopathy and heart failure-related hospitalizations: a value-based analysis","volume":"21","author":"Wittlieb-Weber","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. [Corrected]","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.01.005","article-title":"miRNA expression in pediatric failing human heart","volume":"57","author":"Stauffer","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib11","doi-asserted-by":"crossref","first-page":"e94249","DOI":"10.1172\/jci.insight.94249","article-title":"Pediatric dilated cardiomyopathy hearts display a unique gene expression profile","volume":"2","author":"Tatman","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhlto.2025.100331_bib12","doi-asserted-by":"crossref","first-page":"e94382","DOI":"10.1172\/jci.insight.94382","article-title":"Pediatric and adult dilated cardiomyopathy represent distinct pathological entities","volume":"2","author":"Patel","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhlto.2025.100331_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.healun.2007.02.004","article-title":"Home inotropic therapy in children","volume":"26","author":"Berg","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/apa.16738","article-title":"Long-term milrinone therapy in children with dilated cardiomyopathy","volume":"112","author":"Brown","year":"2023","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","article-title":"Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure","volume":"12","author":"Price","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCHEARTFAILURE.114.001218","article-title":"Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy","volume":"8","author":"Nakano","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","article-title":"Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy","volume":"35","author":"Miyamoto","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2025.100331_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jhlto.2025.100331_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpeds.2017.08.055","article-title":"Fibrosis-related gene expression in single ventricle heart disease","volume":"191","author":"Nakano","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2014.02.030","article-title":"Gene expression and beta-adrenergic signaling are altered in hypoplastic left heart syndrome","volume":"33","author":"Miyamoto","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jacbts.2022.09.013","article-title":"Cardiac transcriptome remodeling and impaired bioenergetics in single-ventricle congenital heart disease","volume":"8","author":"Garcia","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jhlto.2025.100331_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.healun.2021.01.011","article-title":"Systemic ventricular assist device support in Fontan patients: a report by ACTION","volume":"40","author":"Cedars","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib24","doi-asserted-by":"crossref","unstructured":"Konduri, A., et al., Experience with SGLT2 Inhibitors in Patients with Single Ventricle Congenital Heart Disease and Fontan Circulatory Failure. Pediatr Cardiol, 2023.","DOI":"10.1007\/s00246-023-03332-5"},{"key":"10.1016\/j.jhlto.2025.100331_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010123","article-title":"Considerations for advanced heart failure consultation in individuals with fontan circulation: recommendations from ACTION","volume":"16","author":"Lubert","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cardfail.2021.10.016","article-title":"Contemporary provider management practices and attitudes toward referral for advanced heart failure therapies in fontan patients across North America","volume":"28","author":"Sadat-Hossieny","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.cardfail.2024.02.015","article-title":"Achieving consensus: severity-graded definitions of Fontan-associated complications to characterize fontan circulatory failure","volume":"30","author":"Schumacher","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF00798207","article-title":"Grading the severity of congestive heart failure in infants","volume":"13","author":"Ross","year":"1992","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21037\/cdt-20-358","article-title":"Medical management of pediatric heart failure","volume":"11","author":"Ahmed","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jhlto.2025.100331_bib31","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00431-022-04768-2","article-title":"Diuretics in pediatrics","volume":"182","author":"Lava","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2020.06.022","article-title":"Loop diuretic prescription and 30-day outcomes in older patients with heart failure","volume":"76","author":"Faselis","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib33","series-title":"An account of the foxglove, and some of its medical uses: with practical remarks on dropsy, and other diseases","first-page":"207","author":"Withering","year":"1785"},{"key":"10.1016\/j.jhlto.2025.100331_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0974-2069.58317","article-title":"Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?","volume":"2","author":"Jain","year":"2009","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib35","doi-asserted-by":"crossref","first-page":"e002376","DOI":"10.1161\/JAHA.115.002376","article-title":"Digoxin use is associated with reduced interstage mortality in patients with no history of arrhythmia after stage I palliation for single ventricle heart disease","volume":"5","author":"Brown","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhlto.2025.100331_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.CIR.83.2.523","article-title":"Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy","volume":"83","author":"Bengur","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00794837","article-title":"The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy","volume":"14","author":"Lewis","year":"1993","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","article-title":"Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)","volume":"193","author":"Shaddy","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jhlto.2025.100331_bib40","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.123.066605","article-title":"Sacubitril\/Valsartan in pediatric heart failure (PANORAMA-HF): a randomized, multicenter, double-blind trial","volume":"150","author":"Shaddy","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/phe.09.65","article-title":"Role of beta-blocker therapy in pediatric heart failure","volume":"4","author":"Patel","year":"2010","journal-title":"Ped Health"},{"key":"10.1016\/j.jhlto.2025.100331_bib42","first-page":"74","article-title":"Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report","volume":"53","author":"Gachara","year":"2001","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jhlto.2025.100331_bib43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.healun.2003.07.025","article-title":"Carvedilol in children with cardiomyopathy: 3-year experience at a single institution","volume":"23","author":"Rusconi","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjcard.2007.11.023","article-title":"Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers","volume":"101","author":"Flannery","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2025.100331_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015916","article-title":"Elevated heart rate and survival in children with dilated cardiomyopathy: a multicenter study from the pediatric cardiomyopathy registry","volume":"9","author":"Rossano","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhlto.2025.100331_bib47","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","article-title":"Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease","volume":"64","author":"DiFrancesco","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jhlto.2025.100331_bib48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jhlto.2025.100331_bib49","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib50","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","article-title":"Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction","volume":"77","author":"Santos-Gallego","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.122.060402","article-title":"Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HF","volume":"146","author":"Selvaraj","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","article-title":"Early clinical experience with Dapagliflozin in children with heart failure","volume":"44","author":"Newland","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac Myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib56","unstructured":"A. Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction (COMET-HF). 2024."},{"key":"10.1016\/j.jhlto.2025.100331_bib57","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/ejhf.1933","article-title":"Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial","volume":"22","author":"Voors","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jhlto.2025.100331_bib59","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/pr.2017.126","article-title":"Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy","volume":"82","author":"Blakeslee","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jhlto.2025.100331_bib60","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib61","doi-asserted-by":"crossref","first-page":"118056","DOI":"10.1016\/j.biopha.2025.118056","article-title":"Contemporary insights into elamipretide\u2019s mitochondrial mechanism of action and therapeutic effects","volume":"187","author":"Sabbah","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhlto.2025.100331_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Reid Thompson","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jhlto.2025.100331_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpeds.2019.09.049","article-title":"Pediatric heart failure: an evolving public health concern","volume":"218","author":"Nakano","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib65","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cardfail.2024.10.445","article-title":"Suboptimal titration of heart failure medications in pediatric patients: baseline data from ACTION","volume":"31","author":"Nandi","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00246-022-02960-7","article-title":"Heart failure with preserved ejection fraction in children","volume":"44","author":"Das","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib67","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib68","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib69","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jhlto.2025.100331_bib70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2009.11.007","article-title":"The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis","volume":"16","author":"Shah","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib71","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100331_bib72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","article-title":"Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-preserved trial","volume":"145","author":"Butler","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.674156","article-title":"Rehabilitation in pediatric heart failure and heart transplant","volume":"9","author":"Ubeda Tikkanen","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib74","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1651-2227.1995.tb13499.x","article-title":"Congestive heart failure caused by vitamin D deficiency?","volume":"84","author":"Brunvand","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jchf.2017.11.015","article-title":"No obesity paradox in pediatric patients with dilated cardiomyopathy","volume":"6","author":"Castleberry","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2019.10.022","article-title":"Disorders of adjustment, mood, and anxiety in children and adolescents undergoing heart transplantation and the association of ventricular assist device support","volume":"217","author":"Diaz","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhlto.2025.100331_bib77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0974-2069.84655","article-title":"Hypocalcemic cardiomyopathy presenting as cardiogenic shock","volume":"4","author":"Gupta","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0884533617712502","article-title":"Optimizing nutrition in pediatric heart failure: the crisis is over and now it's time to feed","volume":"33","author":"Lewis","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jhlto.2025.100331_bib79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/hrt.2007.119792","article-title":"Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure","volume":"94","author":"Maiya","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jhlto.2025.100331_bib80","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhlto.2025.100331_bib81","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/dc21-1113","article-title":"Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes","volume":"45","author":"Wright","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhlto.2025.100331_bib82","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","article-title":"The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report-2019; Focus theme: Donor and recipient size match","volume":"38","author":"Rossano","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib83","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.healun.2020.07.008","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics","volume":"39","author":"Singh","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100331_bib84","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.healun.2016.08.018","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus theme: primary diagnostic indications for transplant","volume":"35","author":"Rossano","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib85","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.athoracsur.2023.11.035","article-title":"Seventh annual society of thoracic surgeons pedimacs report","volume":"117","author":"Peng","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jhlto.2025.100331_bib86","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jacc.2024.10.083","article-title":"Outcomes for children with congenital heart disease undergoing ventricular assist device implantation: an ACTION registry analysis","volume":"85","author":"Amdani","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib87","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCULATIONAHA.105.571422","article-title":"The national heart, lung, and blood institute pediatric circulatory support program","volume":"113","author":"Baldwin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib88","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacep.2023.11.008","article-title":"Multicenter Study of survival benefit of cardiac resynchronization therapy in pediatric and congenital heart disease","volume":"10","author":"Chubb","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib90","doi-asserted-by":"crossref","first-page":"ytad422","DOI":"10.1093\/ehjcr\/ytad422","article-title":"Safety and utility of CardioMEMS device for remote pulmonary artery monitoring in paediatric Fontan patients: a case series","volume":"7","author":"Bhat","year":"2023","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jhlto.2025.100331_bib91","article-title":"Hemodynamic monitoring of pediatric patients with heart failure and pulmonary hypertension using CardioMEMS","volume":"3","author":"Labrandero","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jhlto.2025.100331_bib92","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jchf.2023.05.033","article-title":"Association between wearable device measured activity and patient-reported outcomes for heart failure","volume":"11","author":"Golbus","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib93","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cardfail.2025.03.001","article-title":"Weighing the benefits of wearable devices in heart failure trials","volume":"31","author":"Golbus","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100331_bib94","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.122.061288","article-title":"Prospective association of daily steps with cardiovascular disease: a harmonized meta-analysis","volume":"147","author":"Paluch","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yjmcc.2021.04.006","article-title":"Reconstructing the heart using iPSCs: engineering strategies and applications","volume":"157","author":"Cho","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jhlto.2025.100331_bib96","doi-asserted-by":"crossref","first-page":"eaaw2459","DOI":"10.1126\/sciadv.aaw2459","article-title":"Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels","volume":"5","author":"Skylar-Scott","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhlto.2025.100331_bib97","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jhlto.2025.100331_bib98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCULATIONAHA.121.056600","article-title":"Distinct transcriptomic and proteomic profile specifies patients who have heart failure with potential of myocardial recovery on mechanical unloading and circulatory support","volume":"147","author":"Drakos","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2025.100331_bib99","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.healun.2022.05.015","article-title":"Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support","volume":"41","author":"Kanwar","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100331_bib100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.healun.2015.01.979","article-title":"Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy","volume":"34","author":"Miyamoto","year":"2015","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib101","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.healun.2022.07.007","article-title":"Biology of myocardial recovery in advanced heart failure with long-term mechanical support","volume":"41","author":"Tseliou","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100331_bib102","doi-asserted-by":"crossref","first-page":"349","DOI":"10.21037\/tp.2019.07.12","article-title":"Collaboration and new data in ACTION: a learning health care system to improve pediatric heart failure and ventricular assist device outcomes","volume":"8","author":"Peng","year":"2019","journal-title":"Transl Pediatr"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:30:08Z","timestamp":1758785408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133425001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":102,"alternative-id":["S2950133425001260"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100331","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric heart failure: Current approach and treatment","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100331"}}